New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Acasti Pharma Inc.
ACST
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

34M

Biotechnology

Next Earning date - 11 Nov 2024

34M

Biotechnology

Next Earning date - 11 Nov 2024

3.37USD
Shape0.13 ( 4.01%)
favorite-chart

Relative Strenght

17
favorite-chart

Volume Buzz

1%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

6%

Quote Panel

Shape
Updated October 25, 2024
1W 4.66 % 1M 9.77 % 3M 22.10 % 1Y 38.68 %

Key Metrics

Shape
  • Market Cap

    34.17M


  • Shares Outstanding

    10.14M


  • Share in Float

    6.25M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    3.37


  • Average Volume

    27364


  • Beta

    1.523


  • Range

    1.98-3.6


  • Industry

    Biotechnology


  • Website

    https://www.acastipharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.62x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-1.4

EPS

How ACST compares to sector?

P/E Ratio

Relative Strength

Shape

ACST

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.83

Shape-663%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.66
vs 0.18

Q4.22

arrow
arrow

N/A

-0.54
vs -0.54

Q1.23

arrow
arrow

N/A

-2.89
vs -0.44

Q2.23

arrow
arrow

N/A

-0.34
vs -0.60

Q3.23

arrow
arrow

N/A

-0.19
vs -0.66

Q4.23

arrow
arrow

N/A

-0.21
vs -0.54

Q1.24

arrow
arrow

N/A

-0.18
vs -2.89

Q2.24

arrow
arrow

N/A

-0.24
vs -0.34

Q3.24

arrow
arrow

N/A

-0.54
vs -0.19

Q4.24

arrow
arrow

N/A

-0.51
vs -0.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-100%

NA  vs 115K

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

-32000.00  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

+100%

NA  vs -32000

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-5%

-0.05
vs -0.04

Q4.22

arrow
arrow

-4%

-0.04
vs -0.05

Q1.23

arrow
arrow

-43%

-0.43
vs -0.04

Q2.23

arrow
arrow

-6%

-0.06
vs -0.43

Q3.23

arrow
arrow

-6%

-0.06
vs -0.06

Q4.23

arrow
arrow

-4%

-0.04
vs -0.06

Q1.24

arrow
arrow

-5%

-0.05
vs -0.04

Q2.24

arrow
arrow

-4%

-0.04
vs -0.05

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

20

20
vs 25

-20%

Q2.21

arrow
arrow

20

20
vs 20

NA

Q3.21

arrow
arrow

2

2
vs 20

-90%

Q4.21

arrow
arrow

1

1
vs 2

-50%

Q1.22

arrow
arrow

2

2
vs 1

100%

Q2.22

arrow
arrow

1

1
vs 2

-50%

Q4.22

arrow
arrow

1

1
vs NA

NA

Q1.23

arrow
arrow

1

1
vs 1

NA

Earnings Growth

Latest News